AV
ARCH Venture Fund XII, L.P. disclosed a 8.4% stake in PRME
ARCH Venture Fund XII, L.P. reported owning 8.4% of Prime Medicine, Inc. (PRME) (18,642,036 shares) in a Schedule 13D filed Nov 13, 2026.
A 13D means the holder may push for changes at the company.